पदोन्नति कार्यक्रम Adynxx Inc
उन्नत शेड्यूल
सरल ग्राफ
कंपनी के बारे में Adynxx Inc
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.ISIN | US00784D1037 |
---|---|
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 16.94 |
Дивиденд ао | 7.35 |
Сайт | https://www.adynxx.com |
Цена ао | 0.0001 |
प्रति दिन मूल्य परिवर्तन: | 0% (0.0001) |
---|---|
प्रति सप्ताह मूल्य परिवर्तन: | 0% (0.0001) |
प्रति माह मूल्य परिवर्तन: | 0% (0.0001) |
3 महीने में कीमत में बदलाव: | 0% (0.0001) |
छह महीने में कीमत में बदलाव: | 0% (0.0001) |
प्रति वर्ष मूल्य परिवर्तन: | 0% (0.0001) |
3 वर्षों में मूल्य परिवर्तन: | 0% (0.0001) |
5 वर्षों में मूल्य परिवर्तन: | -100% (2.695) |
वर्ष की शुरुआत से मूल्य परिवर्तन: | 0% (0.0001) |
|
बहुत मूल्यवान समझना
|
क्षमता
|
|||||||||||||||||||||||||||||||||||||
लाभांश
|
कर्तव्य
|
विकास का आवेग
|
पर्यवेक्षक | नौकरी का शीर्षक | भुगतान | जन्म का साल |
---|---|---|---|
Mr. Richard Orr Esq., J.D. | President, CEO, Principal Financial Officer & Director | 1961 (64 वर्ष) | |
Dr. Julien Mamet Ph.D. | Founder, Chief Scientific Officer & Director | 1976 (49 साल) | |
Mr. William Martin | Executive Vice President of Corporate Development & Operations | ||
Ms. Dina Gonzalez | Principal Accounting Officer & Senior VP of Finance | ||
Ms. Kimberley Hebert | Senior Director of Clinical Operations |
पता: United States, San Francisco, 100 Pine Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.adynxx.com
वेबसाइट: https://www.adynxx.com